Antagonistic effects of N-ethylmaleimide on platelets treated with agents that are known to increase levels of cyclic AMP.
D000241:Adenosine / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D000242:Cyclic AMP / Q000096:biosynthesis*; D004176:Dipyridamole / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008315:Malondialdehyde / Q000378:metabolism; D010208:Papaverine / Q000494:pharmacology; D011457:Prostaglandins D / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D011457:Prostaglandins D; D011458:Prostaglandins E; D012701:Serotonin; D008315:Malondialdehyde; D004176:Dipyridamole; D010208:Papaverine; D000242:Cyclic AMP; D000241:Adenosine; D005033:Ethylmaleimide; D001241:Aspirin; D007213:Indomethacin